Masson Kristina has filed 4 insider transactions across 1 company since November 2023.
Most recent transaction: a tax payment of 490 shares of Acrivon Therapeutics, Inc. ($ACRV) on August 14, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aug. 14, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Masson Kristina | EVP - Business Operations | F | Common Stock | 490 | $7.02 | 2,819,375.0000 | 22,078,190 | 0.02% | 0.00% |
| May 14, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Masson Kristina | EVP - Business Operations | F | Common Stock | 490 | $8.36 | 2,879,630.0000 | 22,078,190 | 0.02% | 0.00% |
| Feb. 14, 2024 | Acrivon Therapeutics, Inc. | $ACRV | Masson Kristina | EVP - Business Operations | F | Common Stock | 579 | $3.40 | 2,935,038.0000 | 22,078,190 | 0.02% | 0.00% |
| Nov. 14, 2023 | Acrivon Therapeutics, Inc. | $ACRV | Masson Kristina | EVP - Business Operations | F | Common Stock | 1900 | $5.08 | 2,977,478.0000 | 0 | 0.06% | 0.00% |